These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A study on Mallory bodies. Isolation, ultrastructure and preliminary biochemical characterization of Mallory bodies from livers of alcoholic cirrhosis and malignant hepatoma. Okamura K Acta Pathol Jpn; 1976 Nov; 26(6):649-70. PubMed ID: 189565 [TBL] [Abstract][Full Text] [Related]
7. Mallory body formation in hepatic nodules of mice ingesting dieldrin. Meierhenry EF; Ruebner BH; Gershwin ME; Hsieh LS; French SW Lab Invest; 1981 Apr; 44(4):392-6. PubMed ID: 6259443 [TBL] [Abstract][Full Text] [Related]
8. [Usefulness of immunocytochemistry in the identification of Mallory bodies. Theoretical analysis about their formation]. Siegmund I; Norambuena L Rev Med Chil; 1996 Oct; 124(10):1193-9. PubMed ID: 9239906 [TBL] [Abstract][Full Text] [Related]
9. Rearrangement of the hepatocyte cytoskeleton after toxic damage: involution, dispersal and peripheral accumulation of Mallory body material after drug withdrawal. Denk H; Franke WW Eur J Cell Biol; 1981 Feb; 23(2):241-9. PubMed ID: 7193580 [TBL] [Abstract][Full Text] [Related]
10. On the three-dimensional structure of quick-frozen hepatic Mallory bodies with special reference to the appearance of cytoplasmic vesicles. Irie T; Koyama W; Ikeuchi Y; Kanaseki T Cell Struct Funct; 1991 Feb; 16(1):1-16. PubMed ID: 1709594 [TBL] [Abstract][Full Text] [Related]
11. High molecular weight component of Mallory bodies detected by a monoclonal antibody. Zatloukal K; Denk H; Spurej G; Lackinger E; Preisegger KH; Franke WW Lab Invest; 1990 Apr; 62(4):427-34. PubMed ID: 1692099 [TBL] [Abstract][Full Text] [Related]
12. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products. Preisegger KH; Stumptner C; Riegelnegg D; Brown PC; Silverman JA; Thorgeirsson SS; Denk H Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270 [TBL] [Abstract][Full Text] [Related]
14. Use of a specific monoclonal antibody to detect Mallory bodies in liver disease. Leevy CB; Sameshima Y; Yoshioka K; Leevy CM; Kanagasundaram N; Unoura M J Assoc Acad Minor Phys; 1990; 1(2):24-5, 28-30. PubMed ID: 2135694 [TBL] [Abstract][Full Text] [Related]
15. [Changes in the intermediate filament cytoskeleton of liver cells in alcoholic liver injury]. Denk H; Lackinger E Wien Klin Wochenschr; 1985 Apr; 97(8):354-8. PubMed ID: 2581375 [TBL] [Abstract][Full Text] [Related]
16. Immunological and biochemical characterization of the keratin-related component of Mallory bodies: a pathological pattern of hepatocytic cytokeratins. Denk H; Krepler R; Lackinger E; Artlieb U; Franke WW Liver; 1982 Sep; 2(3):165-75. PubMed ID: 6184592 [TBL] [Abstract][Full Text] [Related]
17. [Experimental induction of Mallory bodies in mice by griseofulvin treatment (author's transl)]. Kosaka Y; Akeda S; Kondo I; Okuda Y; Hagiwara M; Fujita K Nihon Shokakibyo Gakkai Zasshi; 1981 Oct; 78(10):1962-8. PubMed ID: 6276593 [No Abstract] [Full Text] [Related]
18. Pathology of cytoskeleton of liver cells: demonstration of mallory bodies (alcoholic hyalin) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes. Denk H; Franke WW; Dragosics B; Zeiler I Hepatology; 1981; 1(1):9-20. PubMed ID: 6169613 [No Abstract] [Full Text] [Related]
19. Hepatocellar hyalin (Mallory bodies) in long term griseofulvin-treated mice: a new experimental model for the study of hyalin formation. Denk H; Gschnait F; Wolff K Lab Invest; 1975 Jun; 32(6):773-6. PubMed ID: 50498 [TBL] [Abstract][Full Text] [Related]
20. [Ultrastructural heterogeneity and assumed mode of formation of Mallory bodies in acute alcoholic hepatitis and in experimental hepatitis]. Vic P; Sablier G; Humeau C; Sentein P; Michel H C R Seances Acad Sci D; 1980 Sep; 291(3):341-7. PubMed ID: 6777056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]